PICOCELA INC (PCLA) Fundamental Analysis & Valuation

NASDAQ:PCLA • US71989C2089

Current stock price

2.51 USD
-0.01 (-0.4%)
Last:

This PCLA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PCLA Profitability Analysis

1.1 Basic Checks

  • PCLA had negative earnings in the past year.
  • PCLA had a negative operating cash flow in the past year.
PCLA Yearly Net Income VS EBIT VS OCF VS FCFPCLA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -200M -400M -600M

1.2 Ratios

  • PCLA has a worse Return On Assets (-86.63%) than 91.49% of its industry peers.
  • PCLA has a worse Return On Equity (-176.89%) than 89.36% of its industry peers.
Industry RankSector Rank
ROA -86.63%
ROE -176.89%
ROIC N/A
ROA(3y)-31.59%
ROA(5y)N/A
ROE(3y)-75.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PCLA Yearly ROA, ROE, ROICPCLA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • PCLA has a better Gross Margin (54.75%) than 72.34% of its industry peers.
  • The Profit Margin and Operating Margin are not available for PCLA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PCLA Yearly Profit, Operating, Gross MarginsPCLA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. PCLA Health Analysis

2.1 Basic Checks

  • PCLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The debt/assets ratio for PCLA is higher compared to a year ago.
PCLA Yearly Total Debt VS Total AssetsPCLA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • PCLA has an Altman-Z score of -2.70. This is a bad value and indicates that PCLA is not financially healthy and even has some risk of bankruptcy.
  • PCLA has a worse Altman-Z score (-2.70) than 72.34% of its industry peers.
  • A Debt/Equity ratio of 0.03 indicates that PCLA is not too dependend on debt financing.
  • PCLA has a Debt to Equity ratio (0.03) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -2.7
ROIC/WACCN/A
WACC1.38%
PCLA Yearly LT Debt VS Equity VS FCFPCLA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 500M -500M

2.3 Liquidity

  • PCLA has a Current Ratio of 2.19. This indicates that PCLA is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 2.19, PCLA perfoms like the industry average, outperforming 48.94% of the companies in the same industry.
  • PCLA has a Quick Ratio of 1.74. This is a normal value and indicates that PCLA is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.74, PCLA is in line with its industry, outperforming 46.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 1.74
PCLA Yearly Current Assets VS Current LiabilitesPCLA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. PCLA Growth Analysis

3.1 Past

  • PCLA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -321.37%.
  • PCLA shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.74%.
EPS 1Y (TTM)-321.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.87%
Revenue 1Y (TTM)23.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-9.3%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PCLA Yearly Revenue VS EstimatesPCLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 200M 400M 600M

More info and screens

Find the best growth stocksShow best growing peers

0

4. PCLA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PCLA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PCLA Price Earnings VS Forward Price EarningsPCLA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PCLA Per share dataPCLA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PCLA Dividend Analysis

5.1 Amount

  • No dividends for PCLA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PCLA Fundamentals: All Metrics, Ratios and Statistics

PICOCELA INC

NASDAQ:PCLA (4/7/2026, 4:10:12 PM)

2.51

-0.01 (-0.4%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.36%
Inst Owner Change54.26%
Ins Owners74.47%
Ins Owner ChangeN/A
Market Cap10.43M
Revenue(TTM)1.04B
Net Income(TTM)-796.15M
AnalystsN/A
Price TargetN/A
Short Float %0.87%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.6
P/FCF N/A
P/OCF N/A
P/B 3.7
P/tB 4.07
EV/EBITDA N/A
EPS(TTM)-2.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)-0.46
OCFYN/A
SpS1.56
BVpS0.68
TBVpS0.62
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -86.63%
ROE -176.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.75%
FCFM N/A
ROA(3y)-31.59%
ROA(5y)N/A
ROE(3y)-75.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 194.6%
Cap/Sales 4.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.19
Quick Ratio 1.74
Altman-Z -2.7
F-Score6
WACC1.38%
ROIC/WACCN/A
Cap/Depr(3y)189.6%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.85%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-321.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-9.3%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y67.18%
OCF growth 3YN/A
OCF growth 5YN/A

PICOCELA INC / PCLA Fundamental Analysis FAQ

What is the fundamental rating for PCLA stock?

ChartMill assigns a fundamental rating of 1 / 10 to PCLA.


What is the valuation status for PCLA stock?

ChartMill assigns a valuation rating of 0 / 10 to PICOCELA INC (PCLA). This can be considered as Overvalued.


How profitable is PICOCELA INC (PCLA) stock?

PICOCELA INC (PCLA) has a profitability rating of 1 / 10.


What is the financial health of PICOCELA INC (PCLA) stock?

The financial health rating of PICOCELA INC (PCLA) is 3 / 10.